Transplant Diagnostic Market Forecast Report, 2018-2026

Transplant Diagnostic Market (Screening - Pre-Transplant Diagnostic, Post-Transplant Diagnostic; Technique - Molecular Assay, Non-Molecular Assay; Application - Stem Cell Transplantation, Solid Organ Transplantation (Kidney, Liver, Heart, Lungs, Pancreas, Small Bowel); Product and Services - Reagents and Consumables, Instruments, Software; End user - Hospital and Transplant Centers, Research Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 - 2026

Transplant Diagnostic Market – Snapshot

The global transplant diagnostic market is expanding due to the increasing number of patients emphasizing on early patient profiling during organ transplantation and rising adoption of transplant diagnostic techniques. The global transplant diagnostic market was valued at US$ 730.9 Mn in 2017 and is projected to surpass US$ 1,289.3 Mn by 2026, expanding at a compound annual growth rate (CAGR) of more than 6.5% from 2018 to 2026. The global market is expanding at a relatively higher growth rate owing to increasing bone marrow transplantation practices, high incidences of pediatric transplantation surgery, occurrence of kidney disorder among geriatric population, and increasing clinical evidence to establish clinical efficacy of molecular assay technique.

Transplant diagnostic is an administrative as well as clinical tool that helps improve operational efficiency of transplantation technique. Transplant diagnostic aids the patients suffering from cancer in order to improve overall operational efficiency as well as patient care. High prevalence and incidence rates of kidney dysfunction, cardiac diseases, increase in number of cases of lungs disorder and orthopedic injuries in the global population has led to the increase in patient flow to private clinics and hospitals. These factors, collectively, are projected to drive the demand for transplant diagnostic in the near future. Furthermore, the compatibility of markers increases the probability of graft survival and decreases severe immunologic transplant complications, which in turn is estimated to fuel the transplant diagnostic market in the near future.

transplant-diagnostics-market.jpg

The global transplant diagnostic market has been broadly segmented based on screening, technique, product & services, application, end-user, and region. In terms of application, the global market has been categorized into stem cell transplantation and solid organ transplantation. The solid organ transplantation segment has been further sub-segmented into kidney, liver, heart, lungs, pancreas, and small bowel. The kidney transplant sub-segment accounted for a key share of the solid organ transplantation segment, in terms of revenue, of the global market in 2017. The liver sub-segment is estimated to expand at a prominent growth rate during the forecast period, and the sub-segment is estimated to report significant gain in market share by the end of 2026. Liver transplant diagnostic is increasingly gaining popularity among cancer patients and physicians, which is also a major factor that is estimated to drive the liver sub-segment between 2018 and 2026.

In terms of technique, the global transplant diagnostic has been classified into molecular assay and non-molecular assay. The non-molecular assay segment dominated the global market and is likely to maintain its dominance by the end of 2026 with marginal increase in its year-on-year growth rate. Rapid advances in the fields of transplant medicine and cancer treatment and the ever-growing implementation of immunomodulatory regimens led to significant increase in the prevalence and prolonged survival of people in immunocompromised states. These are key factors which have led the non-molecular assay segment to hold a prominent share of the global market. Based on screening, the transplant diagnostic market has been bifurcated into pre-transplant diagnostic and post-transplant diagnostic. In terms of product & services, the transplant diagnostic market has been split into reagents & consumables, instruments, and software. Based on end-user, the global market has been segregated into hospital & transplant centers, research laboratories, and others.

In terms of region, the global transplant diagnostic market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and is projected to lose market share by the end of 2026. The market in North America is primarily driven by the rapid increase in geriatric population, high adoption rate of transplantation technique for cancer, and rise in incidence of kidney disorders among geriatric population in the U.S. Moreover, increasing awareness programs about transplantation by pharmaceutical companies is a major practice witnessed in the U.S., which is projected to fuel the transplant diagnostic market in the U.S. during the forecast period. The market in Asia Pacific is expected to expand at a rapid pace during the forecast period. China dominated the transplant diagnostic market in Asia Pacific, whereas the market in India is estimated to expand at a significant CAGR during the forecast period.

Companies such as Bio-Rad Laboratories, Inc., Qiagen N.V., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., and Becton, Dickinson and Company accounted for a major share of the global transplant diagnostic market in 2017 In July 2017, Thermo Fisher Scientific acquired Linkage Biosciences. Linkage Biosciences is presently a part of Thermo Fisher's transplant diagnostics business. Through this acquisition, Thermo Fisher currently provides services to more than 1,000 transplant centres in more than 60 countries. Other global players operating in the market include Ortho Clinical Diagnostics (a part of Carlyle Group), Immucor, Inc., Illumina, Inc., Siemens Healthineers (Siemens AG), and Agilent Technologies. Companies are adopting the strategy of acquisition and collaboration with parallel companies in order to improve and strengthen its geographic presence in the global market.

The global transplant diagnostic market has been segmented as given below:

Screening

  • Pre-Transplant Diagnostic
  • Post-Transplant Diagnostic

Technique

  • Molecular Assay
  • Non-Molecular Assay

Application

  • Solid Organ Transplantation
    • Kidney
    • Liver
    • Heart
    • Lungs
    • Pancreas
    • Small Bowel
    • Stem Cell Transplantation

Product & Services

  • Reagents & Consumables
  • Instruments
  • Software & Services

End-user

  • Hospitals
  • Clinics
  • Rehab centers
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

    1. Preface
         1.1. Market Definition and Scope
         1.2. Market Segmentation
         1.3. Key Research Objectives
         1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary : Global Transplant Diagnostic Market

    4. Market Overview
         4.1. Introduction
                4.1.1. Technique Definition
                4.1.2. Industry Evolution / Developments
         4.2. Overview
         4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunity
                4.3.4. Trends
         4.4. Global Transplant Diagnostic Market Analysis and Forecast, 2016–2026
                4.4.1. Market Revenue Projections (US$ Mn)
         4.5. Market Outlook
         4.6.Regulatory Scenarios
         4.7. Number of Transplantations, by Region/Country
         4.8. Key Success Factors of Top 3 Companies

    5. Global Transplant Diagnostic Market Analysis and Forecast, by Technique
         5.1. Introduction & Definition
         5.2. Key Findings / Developments
         5.3. Global Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
                5.3.1. Molecular Assay
                5.3.2. Non-Molecular Assay
         5.4. Market Attractiveness, by Technique

    6. Global Transplant Diagnostic Market Analysis and Forecast, by Application
         6.1. Introduction & Definition
         6.2. Key Findings / Developments
         6.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
                6.3.1. Solid Organ Transplantation
                         6.3.1.1. Kidney
                         6.3.1.2. Liver
                         6.3.1.3. Heart
                         6.3.1.4. Lungs
                         6.3.1.5. Pancreas
                         6.3.1.6. Small Bowel
                6.3.2. Stem Cell Transplantation
         6.4. Market Attractiveness, by Application

    7. Global Transplant Diagnostic Market Analysis and Forecast, by Screening
         7.1. Introduction & Definition
         7.2. Key Findings / Developments
         7.3. Global Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
                7.3.1. Pre-Transplant Diagnostic
                7.3.2. Post-Transplant Diagnostic
                7.3.3. Instruments
         7.4. Market Attractiveness, by Screening

    8. Global Transplant Diagnostic Market Analysis and Forecast, by Product & Services
         8.1. Introduction & Definition
         8.2. Key Findings / Developments
         8.3. Global Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
                8.3.1. Reagents & Consumables
                8.3.2. Instruments
                8.3.3. Software & Services
         8.4. Market Attractiveness, by Product & Services

    9. Global Transplant Diagnostic Market Analysis and Forecast, by End-user
         9.1. Introduction & Definition
         9.2. Key Findings / Developments
         9.3. Global Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
                9.3.1. Hospital & Transplant Centers
                9.3.2. Research Laboratories
                9.3.3. Others
         9.4. Market Attractiveness, by End-user

    10. Global Transplant Diagnostic Market Analysis and Forecast, by Region
         10.1.Key Findings
         10.2. Global Transplant Diagnostic Market Value Forecast, by Region
                10.2.1. North America
                10.2.2. Europe
                10.2.3. Asia Pacific
                10.2.4. Latin America
                10.2.5. Middle East & Africa
         10.3.Market Attractiveness, by Country/Region

    11. North America Transplant Diagnostic Market Analysis and Forecast
         11.1.Introduction
                11.1.1. Key Findings
         11.2. North America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
                11.2.1. Molecular Assay
                11.2.2. Non-Molecular Assay
         11.3. North America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
                11.3.1. Solid Organ Transplantation
                         11.3.1.1. Kidney
                         11.3.1.2. Liver
                         11.3.1.3. Heart
                         11.3.1.4. Lungs
                         11.3.1.5. Pancreas
                         11.3.1.6. Small Bowel
                11.3.2. Stem Cell Transplantation
         11.4. North America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
                11.4.1. Pre-Transplant Diagnostic
                11.4.2. Post-Transplant Diagnostic
                11.4.3. Instruments
         11.5. North America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
                11.5.1. Reagents & Consumables
                11.5.2. Instruments
                11.5.3. Software & Services
         11.6. North America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
                11.6.1. Hospital & Transplant Centers
                11.6.2. Research Laboratories
                11.6.3. Others
         11.7. North America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
                11.7.1. U.S.
                11.7.2. Canada
         11.8. North America Transplant Diagnostic Market Attractiveness Analysis
                11.8.1. By Technique
                11.8.2. By Application
                11.8.3. By Screening
                11.8.4. By Product & Services
                11.8.5. By End-user
                11.8.6. By Country

    12. Europe Transplant Diagnostic Market Analysis and Forecast
         12.1.Introduction
                12.1.1. Key Findings
         12.2. Europe Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
                12.2.1. Molecular Assay
                12.2.2. Non-Molecular Assay
         12.3. Europe Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
                12.3.1. Solid Organ Transplantation
                         12.3.1.1. Kidney
                         12.3.1.2. Liver
                         12.3.1.3. Heart
                         12.3.1.4. Lungs
                         12.3.1.5. Pancreas
                         12.3.1.6. Small Bowel
                12.3.2. Stem Cell Transplantation
         12.4. Europe Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
                12.4.1. Pre-Transplant Diagnostic
                12.4.2. Post-Transplant Diagnostic
                12.4.3. Instruments
         12.5. Europe Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
                12.5.1. Reagents & Consumables
                12.5.2. Instruments
                12.5.3. Software & Services
         12.6. Europe Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
                12.6.1. Hospital & Transplant Centers
                12.6.2. Research Laboratories
                12.6.3. Others
         12.7. Europe Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
                12.7.1. Germany
                12.7.2. U.K.
                12.7.3. France
                12.7.4. Spain
                12.7.5. Italy
                12.7.6. Rest of Europe
         12.8. Europe Transplant Diagnostic Market Attractiveness Analysis
                12.8.1. By Technique
                12.8.2. By Application
                12.8.3. By Screening
                12.8.4. By Product & Services
                12.8.5. By End-user
                12.8.6. By Country

    13. Asia Pacific Transplant Diagnostic Market Analysis and Forecast
         13.1.Introduction
                13.1.1. Key Findings
         13.2. Asia Pacific Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
                13.2.1. Molecular Assay
                13.2.2. Non-Molecular Assay
         13.3. Asia Pacific Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
                13.3.1. Solid Organ Transplantation
                         13.3.1.1. Kidney
                         13.3.1.2. Liver
                         13.3.1.3. Heart
                         13.3.1.4. Lungs
                         13.3.1.5. Pancreas
                         13.3.1.6. Small Bowel
                13.3.2. Stem Cell Transplantation
         13.4. Asia Pacific Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
                13.4.1. Pre-Transplant Diagnostic
                13.4.2. Post-Transplant Diagnostic
                13.4.3. Instruments
         13.5. Asia Pacific Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
                13.5.1. Reagents & Consumables
                13.5.2. Instruments
                13.5.3. Software & Services
         13.6. Asia Pacific Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
                13.6.1. Hospital & Transplant Centers
                13.6.2. Research Laboratories
                13.6.3. Others
         13.7. Asia Pacific Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
                13.7.1. China
                13.7.2. Japan
                13.7.3. India
                13.7.4. Australia & New Zealand
                13.7.5. Rest of Asia Pacific
         13.8. Asia Pacific Transplant Diagnostic Market Attractiveness Analysis
                13.8.1. By Technique
                13.8.2. By Application
                13.8.3. By Screening
                13.8.4. By Product & Services
                13.8.5. By End-user
                13.8.6. By Country

    14. Latin America Transplant Diagnostic Market Analysis and Forecast
         14.1.Introduction
                14.1.1. Key Findings
         14.2. Latin America Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
                14.2.1. Molecular Assay
                14.2.2. Non-Molecular Assay
         14.3. Latin America Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
                14.3.1. Solid Organ Transplantation
                         14.3.1.1. Kidney
                         14.3.1.2. Liver
                         14.3.1.3. Heart
                         14.3.1.4. Lungs
                         14.3.1.5. Pancreas
                         14.3.1.6. Small Bowel
                14.3.2. Stem Cell Transplantation
         14.4. Latin America Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
                14.4.1. Pre-Transplant Diagnostic
                14.4.2. Post-Transplant Diagnostic
                14.4.3. Instruments
         14.5. Latin America Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
                14.5.1. Reagents & Consumables
                14.5.2. Instruments
                14.5.3. Software & Services
         14.6. Latin America Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
                14.6.1. Hospital & Transplant Centers
                14.6.2. Research Laboratories
                14.6.3. Others
         14.7. Latin America Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
                14.7.1. Brazil
                14.7.2. Mexico
                14.7.3. Rest of Latin America
         14.8. Latin America Transplant Diagnostic Market Attractiveness Analysis
                14.8.1. By Technique
                14.8.2. By Application
                14.8.3. By Screening
                14.8.4. By Product & Services
                14.8.5. By End-user
                14.8.6. By Country

    15. Middle East & Africa Transplant Diagnostic Market Analysis and Forecast
         15.1.Introduction
                15.1.1. Key Findings
         15.2. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Technique , 2016–2026
                15.2.1. Molecular Assay
                15.2.2. Non-Molecular Assay
         15.3. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Application, 2016–2026
                15.3.1. Solid Organ Transplantation
                         15.3.1.1. Kidney
                         15.3.1.2. Liver
                         15.3.1.3. Heart
                         15.3.1.4. Lungs
                         15.3.1.5. Pancreas
                         15.3.1.6. Small Bowel
                15.3.2. Stem Cell Transplantation
         15.4. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Screening, 2016–2026
                15.4.1. Pre-Transplant Diagnostic
                15.4.2. Post-Transplant Diagnostic
                15.4.3. Instruments
         15.5. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Product & Services, 2016–2026
                15.5.1. Reagents & Consumables
                15.5.2. Instruments
                15.5.3. Software & Services
         15.6. Middle East & Africa Transplant Diagnostic Market Value Forecast, by End-user, 2016–2026
                15.6.1. Hospital & Transplant Centers
                15.6.2. Research Laboratories
                15.6.3. Others
         15.7. Middle East & Africa Transplant Diagnostic Market Value Forecast, by Country, 2016–2026
                15.7.1. GCC countries
                15.7.2. South Africa
                15.7.3. Israel
                15.7.4. Rest of Middle East & Africa
         15.8. Middle East & Africa Transplant Diagnostic Market Attractiveness Analysis
                15.8.1. By Technique
                15.8.2. By Application
                15.8.3. By Screening
                15.8.4. By Product & Services
                15.8.5. By End-user
                15.8.6. By Country

    16. Competition Landscape
         16.1.Market Player – Competition Matrix (by Tier and Size of companies)
         16.2.Market Share Analysis by Company (2017)
         16.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
                16.3.1. Bio-Rad Laboratories, Inc.
                         16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.1.2. Product Portfolio
                         16.3.1.3. SWOT Analysis
                         16.3.1.4. Financial Overview
                         16.3.1.5. Strategic Overview
                16.3.2. Qiagen N.V.
                         16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.2.2. Product Portfolio
                         16.3.2.3. SWOT Analysis
                         16.3.2.4. Financial Overview
                         16.3.2.5. Strategic Overview
                16.3.3. F. Hoffmann-La Roche AG
                         16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.3.2. Product Portfolio
                         16.3.3.3. SWOT Analysis
                         16.3.3.4. Financial Overview
                         16.3.3.5. Strategic Overview
                16.3.4. Thermo Fisher Scientific, Inc.
                         16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.4.2. Product Portfolio
                         16.3.4.3. SWOT Analysis
                         16.3.4.4. Financial Overview
                         16.3.4.5. Strategic Overview
                16.3.5. Becton, Dickinson and Company
                         16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.5.2. Product Portfolio
                         16.3.5.3. SWOT Analysis
                         16.3.5.4. Financial Overview
                         16.3.5.5. Strategic Overview
                16.3.6. Ortho Clinical Diagnostics
                         16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.6.2. Product Portfolio
                         16.3.6.3. SWOT Analysis
                         16.3.6.4. Financial Overview
                         16.3.6.5. Strategic Overview
                16.3.7. Immucor, Inc.
                         16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.7.2. Product Portfolio
                         16.3.7.3. SWOT Analysis
                         16.3.7.4. Financial Overview
                         16.3.7.5. Strategic Overview
                16.3.8. Illumina, Inc.
                         16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.8.2. Product Portfolio
                         16.3.8.3. SWOT Analysis
                         16.3.8.4. Financial Overview
                         16.3.8.5. Strategic Overview
                16.3.9. Siemens Healthineers (Siemens AG)
                         16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.9.2. Product Portfolio
                         16.3.9.3. SWOT Analysis
                         16.3.9.4. Financial Overview
                         16.3.9.5. Strategic Overview
                16.3.10. Agilent Technologies
                         16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                         16.3.10.2. Product Portfolio
                         16.3.10.3. SWOT Analysis
                         16.3.10.4. Financial Overview
                         16.3.10.5. Strategic Overview
                16.3.11. Others

    List of Tables

    Table 01: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 02: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 03: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 04: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
    Table 05: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 06: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 07: Global Transplant Diagnostic Market Value (US$ Mn) Forecast, by Region, 2016–2026
    Table 08: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 09: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 10: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 11: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 12: U.S. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 13: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 14: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 15: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 16: Canada Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 17: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 18: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 19: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 20: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
    Table 21: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 22: North America Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 23: Europe Animal Parasiticides Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 24: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 25: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 26: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 27: France Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 28: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 29: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 30: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 31: U.K. Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 32: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 33: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 34: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 35: Germany Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 36: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 37: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 38: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 39: Spain Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 40: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 41: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 42: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 43: Italy Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 44: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 45: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 46: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 47: Rest of Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 48: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 49: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 50: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 51: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
    Table 52: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 53: Europe Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 54: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 55: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 56: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 57: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 58: Japan Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 59: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 60: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 61: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 62: China Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 63: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 64: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 65: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 66: India Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 67: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 68: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 69: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 70: Australia & New Zealand Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 71: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 72: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 73: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 74: Rest of Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 75: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 76: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 77: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 78: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
    Table 79: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 80: Asia Pacific Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 81: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country, 2016–2026
    Table 82: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 83: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 84: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 85: Brazil Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 86: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 87: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 88: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 89: Mexico Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 90: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 91: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 92: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 93: Rest of Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 94: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 95: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 96: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 97: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
    Table 98: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 99: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026
    Table 100: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
    Table 101: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 102: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 103: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 104: GCC countries Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 105: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 106: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 107: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 108: South Africa Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 109: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 110: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 111: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 112: Israel Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 113: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 114: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 115: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 116: Rest of MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 117: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Screening, 2016–2026
    Table 118: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Technique, 2016–2026
    Table 119: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Application, 2016–2026
    Table 120: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Solid Organ Transplantation, 2016–2026
    Table 121: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by Product & Services, 2016–2026
    Table 122: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast, by End-user, 2016–2026

    List of Figures

    Figure 01: Global Transplant Diagnostic Market Size (US$ Mn) Forecast, 2016–2026
    Figure 02: Global Transplant Diagnostic Market Value Share, by Screening, 2017
    Figure 03: Global Transplant Diagnostic Market Value Share, by Application, 2017
    Figure 04: Global Transplant Diagnostic Market Value Share, by Technique, 2017
    Figure 05: Global Transplant Diagnostic Market Value Share, by End-user, 2017
    Figure 06: Global Transplant Diagnostic Market Value Share, by Product & Services, 2017
    Figure 07: Global Transplant Diagnostic Market Value Share, by Region, 2017
    Figure 08: Global Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
    Figure 09: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pre-Transplant Diagnostic, 2017–2026
    Figure 10: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Post-Transplant Diagnostic, 2017–2026
    Figure 11: Global Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
    Figure 12: Global Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
    Figure 13: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Molecular Assay, 2017–2026
    Figure 14: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Non-Molecular Assay, 2017–2026
    Figure 15: Global Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
    Figure 16: Global Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
    Figure 17: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stem Cell Transplantation, 2017–2026
    Figure 18: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Solid Organ Transplantation, 2017–2026
    Figure 19: Global Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
    Figure 20: Global Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
    Figure 21: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Reagents & Consumables, 2017–2026
    Figure 22: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Software & Services, 2017–2026
    Figure 23: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2017–2026
    Figure 24: Global Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
    Figure 25: Global Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
    Figure 26: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital & Transplant Centers, 2017–2026
    Figure 27: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2026
    Figure 28: Global Transplant Diagnostic Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research Laboratories, 2017–2026
    Figure 29: Global Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
    Figure 30: Global Transplant Diagnostic Market Value Share, by Region, 2018 and 2025
    Figure 31: Global Transplant Diagnostic Market Attractiveness, by Region, 2018–2026
    Figure 32: North America Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 33: North America Transplant Diagnostic Market Value Share, by Country, 2018–2026
    Figure 34: North America Transplant Diagnostic Market Attractiveness, by Country, 2018–2026
    Figure 35: North America Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
    Figure 36: North America Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
    Figure 37: North America Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
    Figure 38: North America Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
    Figure 39: North America Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
    Figure 40: North America Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
    Figure 41: North America Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
    Figure 42: North America Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
    Figure 43: North America Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
    Figure 44: North America Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
    Figure 45: Europe Animal Parasiticides Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 46: Europe Animal Parasiticides Market Value Share, by Country/Sub-region, 2018–2026
    Figure 47: Europe Animal Parasiticides Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 48: Europe Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
    Figure 49: Europe Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
    Figure 50: Europe Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
    Figure 51: Europe Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
    Figure 52: Europe Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
    Figure 53: Europe Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
    Figure 54: Europe Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
    Figure 55: Europe Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
    Figure 56: Europe Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
    Figure 57: Europe Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
    Figure 58: Latin America Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016?2026
    Figure 59: Latin America Transplant Diagnostic Market Value Share, by Country/Sub-region, 2018–2026
    Figure 60: Latin America Transplant Diagnostic Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 61: Latin America Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
    Figure 62: Latin America Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
    Figure 63: Latin America Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
    Figure 64: Latin America Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
    Figure 65: Latin America Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
    Figure 66: Latin America Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
    Figure 67: Latin America Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
    Figure 68: Latin America Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
    Figure 69: Latin America Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
    Figure 70: Latin America Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026
    Figure 71: MEA Transplant Diagnostic Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
    Figure 72: MEA Transplant Diagnostic Market Value Share, by Country/Sub-region, 2018–2026
    Figure 73: MEA Transplant Diagnostic Market Attractiveness, by Country/Sub-region, 2018–2026
    Figure 74: MEA Transplant Diagnostic Market Value Share, by Technique, 2018 and 2026
    Figure 75: MEA Transplant Diagnostic Market Value Share, by Screening, 2018 and 2026
    Figure 76: MEA Transplant Diagnostic Market Value Share, by Application, 2018 and 2026
    Figure 77: MEA Transplant Diagnostic Market Value Share, by Product & Services, 2018 and 2026
    Figure 78: MEA Transplant Diagnostic Market Value Share, by End-user, 2018 and 2026
    Figure 79: MEA Transplant Diagnostic Market Attractiveness, by Screening, 2018–2026
    Figure 80: MEA Transplant Diagnostic Market Attractiveness, by Technique, 2018–2026
    Figure 81: MEA Transplant Diagnostic Market Attractiveness, by Application, 2018–2026
    Figure 82: MEA Transplant Diagnostic Market Attractiveness, by Product & Services, 2018–2026
    Figure 83: MEA Transplant Diagnostic Market Attractiveness, by End-user, 2018–2026

Copyright © Transparency Market Research, Inc. All Rights reserved